Aspen Aerogels Q1 revenue falls 52% YoY to $37.9M; adjusted loss per share $0.28 vs $0.06 prior year

ASPEN AEROGELS INC

2026-Q1 EPS reported -$0.29 revenue$37,884,000

Revenue $37.9M, down from $78.7M; thermal barrier segment revenue dropped 67% to $16.3M on reduced customer demand.
Net loss $23.7M vs $301.2M (prior year included $286.6M impairment); adjusted net loss $23.3M vs $4.8M.
Adjusted EBITDA negative $12.7M vs positive $4.9M in prior year; cash balance $175.6M, up from $158.6M year-end.
Received $37.6M cash from GM commercial settlement; $3.5M recognized as revenue in Q1, remaining $4.9M/quarter through 2027.
East Providence manufacturing facility to have staged restart in May 2026; secured additional subsea pipeline award for Q3 delivery.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ASPEN AEROGELS INC reported first quarter of 2026 results: revenue $37.9 million, net income Net loss was $23.7 million, EPS Net loss per share was $0.29.

Period: first quarter of 2026
Revenue: $37.9 million
Net income: Net loss was $23.7 million
EPS: Net loss per share was $0.29
Result: reported results

Exact text from the filing

Total revenue for the first quarter of 2026 was $37.9 million, compared to $78.7 million in the prior year period.

View on SEC.gov

43 earnings releases filed in the last 30 days. Browse all earnings releases →

ASPEN AEROGELS INC filing history →

Source: SEC EDGAR

accession 0001171843-26-003109

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.